Enanta Pharmaceuticals (ENTA) shares rallied 10.1% in the last trading session to close at $45.67. This move can be attributable to notable volume with a higher number of shares being traded than in a ...
Investors are always looking for stocks that are poised to beat at earnings season and Enanta Pharmaceuticals, Inc. ENTA may be one such company. The firm has earnings coming up pretty soon, and ...
Shares of Enanta Pharmaceuticals (ENTA) have gained 5.1% over the past four weeks to close the last trading session at $5.18, but there could still be a solid upside left in the stock if short-term ...
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million equity holdings threshold to file a report that shows their positions at the end of every quarter.
In this article we will check out the progression of hedge fund sentiment towards Enanta Pharmaceuticals Inc (NASDAQ:ENTA) and determine whether it is a good investment right now. We at Insider Monkey ...
Enanta Pharmaceuticals Inc's ENTA investigational COVID-19 pill, EDP-235, met its primary endpoints of safety and tolerability in its Phase 2 SPRINT trial but yielded mixed results on its ...